(Q46474992)

English

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

Muhammad T Salam

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Juergen Reichardt

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

2

object named as

Giske Ursin

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

author name string

Eila C Skinner

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Tesfaye Dessissa

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

23

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

246-253

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Benign prostatic hyperplasia: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Molecular genetics of steroid 5 alpha-reductase 2 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

5alpha-reductase 2 polymorphisms as risk factors in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Polymorphic markers in the 5α‐reductase type II gene and the incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.12.014

7 January 2021

Identifiers

10.1016/J.UROLONC.2004.12.014

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16018939

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46474992&oldid=2113229076"